ArtBlood
PrivateLast Round
Series B
Nov 1, 2025
Total Funding Raised
$20.84M
Company Overview
ArtBlood operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series A round in September 2024.
ArtBlood is a biotechnology company that develops a cell-based in vitro blood production system intended to solve the problem of blood transfusion shortages.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArtBlood Comparables
Compare ArtBlood with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RedC Biotech | 81% | |
| Scarlet Therapeutics | 77% | |
| Megakaryon Corporation | 75% |
For institutional investors. Book with your work email.
ArtBlood Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 1, 2025 | ||||
| Series A | Sep 24, 2024 | ||||
| Series A | Apr 9, 2024 | ||||
| Grant | Aug 1, 2023 | ||||
| Seed | Jul 1, 2022 |
For institutional investors. Book with your work email.
ArtBlood Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Accelerator | Series A |
| Korea Investment Accelerator | Series A |
| Heungkuk Securities | Series A |
| Korea Development Bank | Series A |
| Ministry of Health and Welfare (South Korea) | Grant |
| Partners Investment | Series A |
| SERIES Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2024
$8M round led by Heungkuk Securities and Partners Investment.
- Aug 1, 2023
Secured $3.46M from the Ministry of Health and Welfare.
For institutional investors. Book with your work email.
ArtBlood Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ArtBlood's valuation, stock price, and market status.
Is ArtBlood a public or private company?
ArtBlood is a private company.
What is the current stock price of ArtBlood?
ArtBlood is a private company, so its shares have no public market price. Caplight tracks ArtBlood's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ArtBlood worth (valuation)?
Valuation information for ArtBlood is not publicly available.
Can I buy ArtBlood stock?
ArtBlood shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ArtBlood's last funding round?
ArtBlood's most recent funding round was Series B on November 1, 2025.
Who are the main investors in ArtBlood?
Key investors in ArtBlood include Korea Investment Accelerator, Korea Investment Accelerator, Heungkuk Securities, Korea Development Bank, Ministry of Health and Welfare (South Korea).
Will ArtBlood IPO soon?
No public IPO plans have been announced for ArtBlood.
How can I track ArtBlood secondary market activity?
Caplight tracks bids, offers, and trades in ArtBlood's shares on secondary markets.